UC San Diego Rad Med

🚨Practice affirming results!🚨 The #radonc docs @UCSDRadMed @UCSDRadRes tried to answer the age-old question of... ❓What is considered a high-risk biochemical recurrence (BCR) after RT to the prostate❓ Is it pre-RT PSA, stage, grade? Is it post-RT PSA doubling time? Turns out, the European & International consensus guidelines for defining high-risk BCR as 1⃣ Gleason 8 or more 2⃣time to BCR of 18 months or less ⭐️are supported by this report!⭐️ In this study of over 7,000 men who had BCR after prostate RT (and it was quite a demographically diverse population!), those with initial Gleason 8+ or time to BCR 18+ months were ☑️as likely to die from prostate cancer as other causes ☑️at a higher risk of increased all-cause death Their low-risk BCR counterparts did not see these outcomes. Given these findings, are we over-treating low-risk BCRs with quality-of-life altering androgen deprivation therapy? 🤔🤔🤔 advancesradonc.org/article/S… @ASTRO_org